PYC THERAPEUTICS LIMITED Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12
Name of entity |
PHYLOGICA LIMITED |
ABN |
48 098 391 961 |
We (the entity) give ASX the following information.
Part 1 - All issuesYou must complete the relevant sections (attach sheets if there is not enough space).
1 | +Class of +securities issued or to be issued | ORDINARY SHARES |
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | 375,000 |
3 | Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | FULLY PAID |
+ See chapter 19 for defined terms.
01/08/2012 Appendix 3B Page 1
4 | Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities? If the additional securities do not rank equally, please state:
| YES |
5 | Issue price or consideration | $0.025 PER SHARE |
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | ISSUED ON THE EXERCISE OF UNLISTED OPTIONS PYCAJ |
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | YES |
6b | The date the security holder resolution under rule 7.1A was passed | 25 NOVEMBER 2016 |
6c | Number of +securities issued without security holder approval under rule 7.1 | NIL |
6d | Number of +securities issued with security holder approval under rule 7.1A | NIL |
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | NIL |
6f | Number of securities issued under an exception in rule 7.2 | 375,000 ORDINARY SHARES EXCEPTION 4 | |
6g | If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation. | N/A | |
6h | If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | N/A | |
6i | Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements | 7.1 REMAINING 15%: 174,268,310 7.1A REMAINING 10%: 199,512,206 | |
7 | Dates of entering +securities into uncertificated holdings or despatch of certificates | 27 JUNE 2017 | |
Number | +Class | ||
8 | Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable) | 2,120,122,067 | Ordinary Shares |
Number | +Class | ||
9 | Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable) | 20,943,750 6,666,667 20,000,000 | PYCAJ Options 23/09/17 $0.025 PYCAA Unlisted Options 30/11/19 $Nil PYCAA Unlisted Options 30/06/18 $Nil |
10 | Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) | NOT APPLICABLE | |
11 | Is security holder approval required? |
12 | Is the issue renounceable or non- renounceable? |
+ See chapter 19 for defined terms.
01/08/2012 Appendix 3B Page 3
13 | Ratio in which the +securities will be offered |
14 | +Class of +securities to which the offer relates |
15 | +Record date to determine entitlements |
16 | Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? |
17 | Policy for deciding entitlements in relation to fractions |
18 | Names of countries in which the entity has +security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. |
19 | Closing date for receipt of acceptances or renunciations |
20 | Names of any underwriters |
21 | Amount of any underwriting fee or commission |
22 | Names of any brokers to the issue |
23 | Fee or commission payable to the broker to the issue |
24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders |
25 | If the issue is contingent on +security holders' approval, the date of the meeting |
26 | Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled |
27 | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders |
Phylogica Limited published this content on 28 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 28 June 2017 01:14:09 UTC.
Original documenthttp://phylogica.com/wp-content/uploads/2017/06/170628_Appendix-3B-option-exercise_1686205.pdf
Public permalinkhttp://www.publicnow.com/view/E80FF7D12F4436F164410F6A263BC16E8DA93753
